Thirty-nine contracting nations of the European Patent Convention—a separate treaty more inclusive than EU membership—have ...
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among ...
Pre-NDA meeting with FDA to discuss brilaroxazine's path to approval for schizophrenia planned in Q4 2025 - - Potential NDA submission for schizophrenia indication targeted for Q2 2026 - - European ...
The AI-driven patent drafts generated by PatentProtector.ai are designed with global filings in mind. The platform ensures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback